641 related articles for article (PubMed ID: 25475403)
1. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
Tanaka K; Moriyama T; Iwasaki C; Takei T; Nitta K
Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
[TBL] [Abstract][Full Text] [Related]
2. Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria.
Iwasaki C; Moriyama T; Tanaka K; Takei T; Nitta K
J Nephropathol; 2016 Apr; 5(2):72-8. PubMed ID: 27152293
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
Tan M; Li W; Zou G; Zhang C; Fang J
Kidney Blood Press Res; 2015; 40(2):200-6. PubMed ID: 25924707
[TBL] [Abstract][Full Text] [Related]
4. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
[TBL] [Abstract][Full Text] [Related]
5. Tonsillectomy plus steroid pulse therapy is the most effective treatment in adult patients with C-Grade I IgA nephropathy, and the weight of the extracted palatine tonsils and Yamamoto scale have no significant correlation with the effects of this treatment.
Kondo N; Moriyama T; Tachikawa M; Tomita E; Hattori A; Yamamura Y; Nonaka M
Auris Nasus Larynx; 2019 Oct; 46(5):764-771. PubMed ID: 30665673
[TBL] [Abstract][Full Text] [Related]
6. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria.
Komatsu H; Sato Y; Miyamoto T; Tamura M; Nakata T; Tomo T; Nishino T; Miyazaki M; Fujimoto S
Clin Exp Nephrol; 2016 Feb; 20(1):94-102. PubMed ID: 26123429
[TBL] [Abstract][Full Text] [Related]
7. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
Mizerska-Wasiak M; Małdyk J; Pańczyk-Tomaszewska M; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Miklaszewska M; Pietrzyk J; Pukajło-Marczyk ; Zwolińska D; Szczepańska M; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
[TBL] [Abstract][Full Text] [Related]
8. Effect of hematuria on the kidney disease progression in IgA nephropathy patients with mild proteinuria and well-preserved renal function.
Liu Y; Chen H; Wang H; Li Z; Li H; Wang F; Jia J; Li D; Yan T
Int Immunopharmacol; 2023 Sep; 122():110635. PubMed ID: 37453157
[TBL] [Abstract][Full Text] [Related]
9. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
Moriyama T; Nakayama K; Ochi A; Amemiya N; Tsuruta Y; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K
Clin Exp Nephrol; 2012 Apr; 16(2):231-7. PubMed ID: 22038185
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function.
Ogura S; Moriyama T; Miyabe Y; Karasawa K; Nitta K
Clin Exp Nephrol; 2021 Oct; 25(10):1103-1110. PubMed ID: 34101029
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function.
Tan M; Fang J; Xu Q; Zhang C; Zou G; Wang M; Li W
Ren Fail; 2019 Nov; 41(1):875-882. PubMed ID: 31517550
[No Abstract] [Full Text] [Related]
12. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria.
Hoshino Y; Kaga T; Abe Y; Endo M; Wakai S; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2015 Oct; 19(5):918-24. PubMed ID: 25672293
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Analysis of Clinical Outcomes in Patients with Immunoglobulin A Nephropathy and Persistent Hematuria Following Renin-Angiotensin System Blockade.
Chen J; Liu S; Xu H; Wang W; Xie Y; Tang W; Yuan Q; Zheng L; Lin L; Fu S; Shen J
Med Sci Monit; 2020 Aug; 26():e922839. PubMed ID: 32822333
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.
Sato H; Ichikawa D; Okada E; Suzuki T; Watanabe S; Shirai S; Shibagaki Y
PLoS One; 2021; 16(5):e0251294. PubMed ID: 34043669
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment hematuria and crescents predict estimated glomerular filtration rate trajectory after methylprednisolone pulse therapy with tonsillectomy for IgA nephropathy.
Nagai M; Kobayashi N; Izumi N; Ohbayashi T; Hotta O; Hamano T
J Nephrol; 2022 Mar; 35(2):441-449. PubMed ID: 34014510
[TBL] [Abstract][Full Text] [Related]
16. Proteinuria in the prognosis of IgA nephropathy.
Aucella F; Netti GS; Piemontese M; Cincione IR; Infante B; Gesualdo L
Minerva Urol Nefrol; 2009 Sep; 61(3):235-48. PubMed ID: 19773725
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of IgA nephropathy in advanced-age patients.
Oshima Y; Moriyama T; Itabashi M; Takei T; Nitta K
Int Urol Nephrol; 2015 Jan; 47(1):137-45. PubMed ID: 25388352
[TBL] [Abstract][Full Text] [Related]
18. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
20. Severity of nephrotic IgA nephropathy according to the Oxford classification.
Moriyama T; Nakayama K; Iwasaki C; Ochi A; Tsuruta Y; Itabashi M; Tsukada M; Takei T; Uchida K; Nitta K
Int Urol Nephrol; 2012 Aug; 44(4):1177-84. PubMed ID: 22231129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
